Literature DB >> 6713360

Hematologic manifestations associated with deletions of the long arm of chromosome 20.

M P Davis, G W Dewald, R V Pierre, H C Hoagland.   

Abstract

We investigated 20 patients with hematologic disorders who had a clone of cells with a deletion of most of a chromosome #20 long arm (20q-) in the bone marrow. Three patients had polycythemia vera (PV), 6 had acute nonlymphocytic leukemia (ANLL), 8 had preleukemia (PL), and 3 had other myeloproliferative disorders. In our laboratory, a 20q- chromosome is found in 6% of patients with PV, 3% of patients with ANLL, and 1% of patients with PL. Among the 6 patients with ANLL and a 20q- abnormality, 3 had erythroleukemia. There were no apparent clinical differences among our patients with 20q- chromosomes compared with other patients with similar disorders who did not have a 20q- chromosome. The breakpoint of the 20q- anomaly, in each instance, was in band 20q11, but it occurred near the centromere at 20q1101 in 16 patients and at the distal part of this band at 20q1109 in 4 patients. Three of the 4 patients with a breakpoint at 20q1109 had PL.

Entities:  

Mesh:

Year:  1984        PMID: 6713360     DOI: 10.1016/0165-4608(84)90009-8

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  11 in total

1.  Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B.

Authors:  S Brown-Shimer; K A Johnson; J B Lawrence; C Johnson; A Bruskin; N R Green; D E Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

Review 2.  The map of chromosome 20.

Authors:  N E Simpson
Journal:  J Med Genet       Date:  1988-12       Impact factor: 6.318

3.  Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins.

Authors:  L Zhu; L Zhu; E Xie; L S Chang
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

4.  Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms.

Authors:  Agnes Fütterer; Miguel R Campanero; Esther Leonardo; Luis M Criado; Juana M Flores; Jesús M Hernández; Jesús F San Miguel; Carlos Martínez-A
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

5.  Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features.

Authors:  G E Verhoef; C De Wolf-Peeters; A Ferrant; S Deprez; P Meeus; M Stul; P Zacheé; J J Cassiman; H Van den Berghe; M A Boogaerts
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

6.  Correlations between cytogenetics and morphology in myelodysplastic syndromes.

Authors:  L Vila; C Charrin; E Archimbaud; D Treille-Ritouet; J Fraisse; P Felman; D Fiere; D Germain
Journal:  Blut       Date:  1990-04

7.  c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders.

Authors:  M M Le Beau; C A Westbrook; M O Diaz; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Recombinant inbred strain and interspecific backcross analysis of molecular markers flanking the murine agouti coat color locus.

Authors:  L D Siracusa; A M Buchberg; N G Copeland; N A Jenkins
Journal:  Genetics       Date:  1989-07       Impact factor: 4.562

9.  Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells.

Authors:  N Quintrell; R Lebo; H Varmus; J M Bishop; M J Pettenati; M M Le Beau; M O Diaz; J D Rowley
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

10.  Role of ribophorin II in the response to anticancer drugs in gastric cancer cell lines.

Authors:  Tein-Ming Yuan; Ruei-Yue Liang; Pin Ju Chueh; Show-Mei Chuang
Journal:  Oncol Lett       Date:  2015-01-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.